Utilization of serum procalcitonin as a biomarker in the diagnosis and treatment of children with bacterial hospital-acq
- PDF / 543,620 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 19 Downloads / 170 Views
Utilization of serum procalcitonin as a biomarker in the diagnosis and treatment of children with bacterial hospital‑acquired pneumonia Wenlong Wang1 · Yitang Zhu1 · Linlin Yin1 · Yaoyao Deng2 · Guoxian Chu3 · Supin Liu4 Received: 10 June 2020 / Accepted: 2 September 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020
Abstract Hospital-acquired pneumonia (HAP) is one of the common infections in hospitalized patients. Early and prompt diagnosis of HAP is important because it aids in the appropriate selection of antibiotics and decreases the mortality and morbidity of patients. The investigation on serum procalcitonin (PCT) levels in pediatric patients is limited. Herein we aimed to evaluate the role of PCT in the early diagnosis of children with bacterial HAP. The study enrolled 264 children (
Data Loading...
